
At least 2,500 people have been killed in Iran since protests broke out at the end of December, the Norway-based human rights organization Hengaw said on Tuesday.
The group noted that its verification team is working daily to document deaths linked to the state crackdown on mass protests.
On Tuesday, Iran Human Rights (IHRNGO), which is also registered in Norway, put the number of demonstrators killed at at least 734, but warned the real toll could be significantly higher, even in the thousands.
"Due to the complete internet shutdown since Thursday night and the severe restrictions on access to information, independent verification of these figures is currently extremely difficult," the IHRNGO report said.
Iranians have been demonstrating for more than two weeks against the authoritarian rule of the Islamic Republic. The protests, triggered by an economic crisis, have meanwhile taken on a nationwide dimension.
Iran has defended its actions against the unrest, justifying the use of force by saying that those taking part were "terrorists" or "rioters."
LATEST POSTS
- 1
Doctors say changes to US vaccine recommendations are confusing parents and could harm kids - 2
Getting ready for a Mechanized World: 10 Positions That computer based intelligence Could Dominate - 3
Sentimental tree to shine at Arctic League annual broadcast - 4
Manual for Wonderful Getaway destination - 5
Figure out How to Alter Your Volvo XC40 for Further developed Solace
See the famous winged horse Pegasus fly in the autumn night sky
Turkiye’s Erdogan calls Israel’s Somaliland recognition ‘unacceptable’
Doggie diversity in size and shape began at least 11,000 years ago
Europe could get 42 more days of summer by the year 2100 due to climate change
Indoor Drinking Fountains: Famous Home Advancements during the Pandemic
Takeaways from AP’s report on potential impacts of Alaska’s proposed Ambler Access Road
France bans Muslim gathering citing risk to participants
Astronaut on ISS captures spectacular orbital video of zodiacal light, auroras and the Pleiades
Corcept Therapeutics shares surge as lead drug gets FDA nod for ovarian cancer













